Neurogene
NGNE
27 hedge funds and large institutions have $27.5M invested in Neurogene in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
8% more funds holding
Funds holding: 25 → 27 (+2)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
19% less capital invested
Capital invested by funds: $34.1M → $27.5M (-$6.63M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$187K |
| 2 |
Franklin Resources
San Mateo,
California
|
+$138K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$114K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$114K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$73.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$1.06M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$313K |
| 3 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$107K |
| 4 |
SIM
Spark Investment Management
New York
|
-$28.9K |
| 5 |
BlackRock
New York
|
-$10.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
UMA
26
USA Mutuals Advisors
Dallas,
Texas
| $2K | +$1.98K | +13 | New |
|
|
SCM
27
Sterling Capital Management
Charlotte,
North Carolina
| – | -$107K | -650 | Closed |
|
|
BIT
28
BlackRock Institutional Trust
San Francisco,
California
| – | -$9K | -55 | Closed |
|
29
Morgan Stanley
New York
| – | -$5.02K | -33 | -97% |
|
NGNE Hedge Fund Activity: Q2 2015 in Review
27 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2015, worth a combined $27.5M — down 19% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NGNE positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $187K. The largest seller was Visium Asset Management, cutting an estimated $1.06M.
- 27 institutional investors held Neurogene (NGNE) as of Q2 2015, up from 25 in Q1 2015.
- Funds reported $27.5M of Neurogene stock for Q2 2015, down 19% quarter-over-quarter.
- 4 funds opened new Neurogene positions in Q2 2015 and 2 closed out, a net change of +2 holders.
- The largest Neurogene buyer in Q2 2015 was Jacobs Levy Equity Management, an estimated $187K added.
- The largest Neurogene seller in Q2 2015 was Visium Asset Management, an estimated $1.06M sold.
Based on aggregated 13F filings for Q2 2015.